Richard Isaacson, MD: Surrogate markers for Alzheimer’s
August 29, 2010
Since the ICAD meeting in July, the topic of surrogate markers to diagnose Alzheimer’s in younger patients decades before noticeable onset of dementia has received considerable mainstream press. We interviewed Alzheimer specialist Richard Isaacson of Miami about how these new markers will change current therapy or speed drug development.
Alzheimer's Disease, Late Breaking Data, Neurology, Univ Miami | apples49 | 
February 21, 2012 2:21 am
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
TrackBack URI
